About the Report
The global sterile vials market is quite progressive in nature, and is anticipated to ascend at around 8.5% CAGR, topping a valuation of US$ 10 billion by 2031. As the requirement for various type of sterile vials such as sterile empty vials, sterile saline-filled vials, sterile media-filled vials, and others is growing steadily, key industry players are forecast to come across new opportunities over the coming years.
This latest study by Fact.MR offers a holistic overview of the global industry potential, demand-supply patterns, and growth and restraining factors for the forecast period of 2021 to 2031. As stated in the report, the United States, Germany, China, Japan, the United Kingdom, and a few other countries will emerge as prominent markets for sterile vials, while 20+ countries will exhibit high growth potential during the forecast period.
Historical Trends Vs. Future Outlook on Sterile Vial Sales
Sales of sterile vials have gained traction over the past decade as the requirement from the key end-use sectors such as clinical labs, compounding labs, and biopharmaceutical companies, to name a few, increased steadily. Additionally, increase in investments by manufacturers to bring in more advanced range of products has further bolstered the growth of key players during the last 5 years from 2016 to 2020.
As advancements in manufacturing sectors are taking over, manufacturers of sterile vials are optimistic to come across higher growth scope in the foreseeable future. Increase in governmental investments in the biopharmaceutical sector, steady expansion of other key end-use industries, and rising demand for COVID-19 sterile vials are expected to offer more growth opportunities for sterile vial suppliers during the forecast period of 2021 to 2031, with the market projected to expand at around 8.5% CAGR over the next ten years.
Know More Details About the Report
How is Demand from Clinical Labs Spearheading Growth of Sterile Vial Suppliers?
Sterile vials are widely used in clinical labs for the administration of various medications, R&D activities, and others. As demand from this sector is surging fast, suppliers of sterile vials are expected to come across ample opportunities in the foreseeable future.
According to a report titled “Clinical Laboratory Improvement Amendment (CLIA)”, published by The Centers for Medicare & Medicaid Services (CMS) on 9th March 2021, the United States clinical laboratory sector is highly potential and expected to expand significantly over the coming years. As stated in the report, in total, CLIA covers approximately 260,000 laboratory entities. This gives a glimpse of the growing opportunities for sterile vial manufactures.
What are the Key Challenges Faced by Sterile Vial Manufacturers?
There are a few restraining factors associated with sterile vials that act as challenges for suppliers and manufacturers, such as-
- High laboratory expenses during production cycle
- Additional storage, transportation, and maintenance costs
- Limitations due to the guidelines imposed by governments & non-profit organizations regarding the usage of plastics
However, with continuous efforts and investments put in R&D activities by manufacturers, the effects of these constraints are expected to get minimized in the near future.
Avail customized purchase options for your needs
What’s Driving Sales of Sterile Vials in the United States?
The United States is huge market for sterile vials and expected to maintain its lead during the forecast period. Steadily rising demand for sterile vials for pharmaceutical applications, and rising demand for sterile vials from compounding labs, clinical labs and other key end-use sectors is boosting sales in the U.S.
According to a report published by Select USA, the U.S. biopharmaceuticals industry accounted for more than US$ 1.3 trillion in economic output, representing 4% of total U.S. output in 2015 alone. As stated in the report, this total economic impact includes US$ 558 billion in revenue from biopharmaceutical businesses and US$ 659 billion from supplier and worker spending. These statistics justify the ample of opportunities for sterile vial providers in the U.S.
What Makes Germany a Heavyweight for Sterile Vial Products?
Germany has been dominating the market in Europe since the past decade, and is likely to exhibit hegemony throughout the forecast period. Backed by advanced clinical laboratories and biopharmaceutical sector, Germany is a hotspot for key players manufacturing sterile vials.
As stated in a report published by the European Commission (EC), Germany is the leading pharmaceutical industry in the European Union (EU), and is subject to exponential growth over the coming years. As stated in the report, more than 500 pharmaceuticals companies are located in Germany, and sales are expected to surpass US$ 48 billion by 2031. No doubt that suppliers of sterile vials are eyeing Germany in order to increase their sales footprint.
Will China’s Huge Pharmaceutical Industry Drive Demand for Sterile Vials?
China has been in the limelight of Asia Pacific’s market for sterile vials since the past decade. Incorporation of cutting-edge technologies by manufacturers and surge in demand from biopharmaceutical and clinical sectors are spurring market growth in China.
As stated in a report published by Select USA, China’s pharmaceutical industry value reached almost US$ 134 billion in 2018, and grew to US$ 154 billion in 2020. According to the report, factors such as government reforms to channel patient volumes to local medical facilities, saturation of major hospital markets in tier-one cities, and others are projected to aid the growth of China’s biopharmaceutical industry over the coming years. This represents the lucrative opportunities awaiting sterile vial manufacturers in the country.
Will India Remain a Prominent Market for Sterile Vials?
Backed by growing number of clinical laboratories and biopharmaceutical & biotechnological research institutes, India is a hotspot for players in the sterile vials industry.
According to a report titled “Biotechnology Industry in India”, published by Invest India, India is among the top 12 destinations for biotechnology in the world, with nearly 3% share in the global industry. As stated in the report, by 2025, India’s biotechnology industry is expected to reach US$ 150 billion, which is bound to throw up lucrative opportunities for sterile vial manufacturers in the country.
Which Product is Spurring Sales of Sterile Vial Manufacturers?
Presently, sterile empty vials are leading the global market in terms of product, and are set to exhibit hegemony over the coming years. There are different types of sterile empty vials that are extensively used in various sectors, such as sterile evacuated vials, sterile nitrogen filled vials, and sterile air filled vials. As a result, demand for plastic sterile vials as well as demand for glass sterile vials is expected to rise further in the near future.
Other key segments fuelling sales in terms of product are sterile liquid-filled vials and individual sterilized components.
Why are Glass Sterile Vials Highly Preferred?
Currently, glass is the most preferred material for manufacturing sterile vials, owing to various advantages such as-
- Complies with the environmental laws and regulations
- Extensive usage
Demand for glass sterile vials for vaccines is also expected to increase. Plastic is the other key material that is aiding overall demand and sales of sterile vials.
An Adaptive Approach to Modern-day Research Needs
With the competition getting fiercer, sterile vial manufacturers are diversifying their products.
- Dalton Pharma Services recently launched its new extensive range of Dalton Clinical Sterile Vials.
- Nipro Corporation recently launched its new eNgage Fully Customizable Vials for diverse end-use sectors.
Historical Data Available for
USD Million for Value
Key Regions Covered
Key Countries Covered
Key Segments Covered
Key Companies Profiled
Market Segmentation by Category
- Sterile Empty Vials
- Sterile Evacuated Vials
- Sterile Nitrogen Filled Vials
- Sterile Air Filled Vials
- Sterile Liquid Filled Vials
- Sterile Saline Filled Vials
- Sterile Media Filled Vials
- Sterile Water Filled Vials
- Individual Sterilized Components
- Sterile Empty Vials
- <2 ml Sterile Vials
- 2 ml to 5 ml Sterile Vials
- 5 ml to 10 ml Sterile Vials
- 10 ml to 20 ml Sterile Vials
- >20 ml Sterile Vials
- Glass Sterile Vials
- Plastic Sterile Vials
- Sterile Vials for Clinical Labs
- Sterile Vials for Compounding Labs
- Sterile Vials for Biopharmaceutical Companies
- Sterile Vials for CMOs
- North America
- Latin America
- Middle East and Africa (MEA)
- East Asia
- South Asia
Sterile Vials Market - Scope Of Report
A recent study by Fact.MR on the sterile vials market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with sterile vials. The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.
A detailed assessment of the value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies manufacturing sterile vials, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including demand, product development, revenue generation, and sales of sterile vials across regions.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account sales during the forecast period. Price point comparison by region with global average price is also considered in the study.
Key Questions Answered in Report
- Which are the most lucrative markets for sterile vials?
- Which factors will impact demand for sterile vials?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the sterile vials market?
- What are the winning strategies of stakeholders in the sterile vials landscape?
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.
Country-specific valuation on demand for sterile vials has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the sterile vials market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQs -
Some of the top companies manufacturing sterile vials are APG Europe, Corning Incorporated, and Dalton Pharma Services.
The United States, Germany, China, Japan, India, the United Kingdom, Canada, Italy, France, and a few others are lucrative markets for sterile vials, and are expected to dominate throughout the forecast period.
Presently, sterile empty vials is the most lucrative in terms of product, and is expected to remain dominant over the forecast period of 2021 to 2031.
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.